Anticonvulsants and anxiolytics: Barbiturates

22,578views

00:00 / 00:00

Videos

Notes

Anticonvulsants and anxiolytics: Barbiturates

Pharmacology

Autonomic medications

Cholinergic receptors

Adrenergic receptors

Cholinomimetics: Direct agonists

Cholinomimetics: Indirect agonists (anticholinesterases)

Muscarinic antagonists

Sympathomimetics: Direct agonists

Sympatholytics: Alpha-2 agonists

Adrenergic antagonists: Presynaptic

Adrenergic antagonists: Alpha blockers

Adrenergic antagonists: Beta blockers

Anticonvulsants

Anticonvulsants and anxiolytics: Barbiturates

Anticonvulsants and anxiolytics: Benzodiazepines

Nonbenzodiazepine anticonvulsants

Migraine medications

Migraine medications

Anesthetics and neuromuscular blockers

General anesthetics

Local anesthetics

Neuromuscular blockers

Neurodegenerative disease medications

Anti-parkinson medications

Medications for neurodegenerative diseases

Opioid analgesics

Opioid agonists, mixed agonist-antagonists and partial agonists

Opioid antagonists

Assessments

Anticonvulsants and anxiolytics: Barbiturates

Flashcards

0 / 7 complete

Flashcards

Anticonvulsants and anxiolytics: Barbiturates

of complete

External References

First Aid

2022

2021

2020

2019

2018

2017

2016

Barbiturates

intoxication and withdrawal p. 594

intravenous anesthetics p. 571

mechanism and use p. 566

naming convention for p. 255

sleep alterations p. 513

Cytochrome P p. -473

barbiturates and p. 566

Delirium p. 581

barbiturate withdrawal p. 594

GABA p. 510

barbiturate effects p. 566

Insomnia

barbiturates for p. 566

Respiratory depression

barbiturates p. 566, 594

Seizures p. 535

barbiturates for p. 566

Transcript

Content Reviewers

Yifan Xiao, MD

Filip Vasiljević, MD

Contributors

Alaina Mueller

Brittany Norton, MFA

Robyn Hughes, MScBMC

Maria Emfietzoglou, MD

Evan Debevec-McKenney

Barbiturates are a class of medications that are used as anticonvulsants to manage seizure disorders; to induce anesthesia in surgical procedures; as anxiolytics to relieve anxiety; and to manage insomnia.

Barbiturates enhance the effect of gamma-aminobutyric acid, or GABA, which is the major inhibitory neurotransmitter in the brain, by binding to its receptor.

It’s pretty well-established that your brain’s really important.

It controls your feelings, your movements, your sleep, your memory… It controls everything, whether you’re aware of it or not.

The cells that make up our brain are called neurons.

Neurons communicate with each other through neurotransmitters.

When one neuron is stimulated, it’ll release excitatory neurotransmitters like glutamate, which bind to receptors on the next neuron.

This causes the next neuron to depolarize and release its own excitatory neurotransmitters, propagating the signal throughout the brain.

Now, we also have inhibitory neurons that will shut down this chain of events.

These neurons release the main inhibitory neurotransmitter in the nervous system, gamma-aminobutyric acid, or GABA, which binds to GABA receptors on other neurons.

These receptors are large multi-unit complexes that form ligand-gated ion channels, which open up to let Cl- ions into the cell.

The influx of negatively charged ions causes hyperpolarization, where the cell’s membrane potential becomes more negative, which means it’s much more difficult for it to depolarize and fire off an action potential, and that means it’s less responsive to stimuli.

Now, there are cases where neurons in the brain start sending out more excitatory signals than normal.

This can occur due to either too much excitation by the excitatory neurotransmitters, or too little inhibition by the inhibitory neurotransmitters like GABA.

Excessive excitatory signals can cause psychiatric disorders like anxiety, and neurological disorders like seizures and epilepsy.

Okay, so one way we can decrease the excitatory signals is by enhancing the effect of inhibitory neurons through medication like barbiturates.

Common medications in this class include amobarbital, butabarbital, methohexital, PENTobarbital, PHENobarbital, and primidone, which is a prodrug of PHENobarbital.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Does bright light have an anxiolytic effect? - an open trial" BMC Psychiatry (2007)
  5. "The use of phenobarbital and other anti-seizure drugs in newborns" Seminars in Fetal and Neonatal Medicine (2017)
  6. "Pediatric Epilepsy" Demos Medical Pub (2001)
  7. "Comparison of the effectiveness of phenobarbital, mephobarbital, primidone, diphenylhydantoin, ethotoin, metharbital, and methylphenylethylhydantoin in motor seizures" Clinical Pharmacology & Therapeutics (1962)
Elsevier

Copyright © 2023 Elsevier, except certain content provided by third parties

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.

RELX